Filter
1755
Filtered Results: 1755
Text search:
Schall,
V.
Featured
Recommendations
186
New Publications
493
Language
Document type
No document type
968
Guidelines
265
Studies & Reports
257
Manuals
126
Strategic & Response Plan
76
Training Material
37
Fact sheets
20
Situation Updates
4
Brochures
1
Infographics
1
Countries / Regions
India
119
Global
83
Western and Central Europe
58
Kenya
49
Uganda
40
Nigeria
32
Latin America and the Carribbean
27
Ghana
24
Ethiopia
23
Philippines
21
Tanzania
21
Bangladesh
21
Zambia
21
Liberia
21
South Africa
20
Eastern Europe
20
Sierra Leone
19
Germany
19
Asia
18
Malawi
17
South–East Asia Region
17
Nepal
16
Rwanda
13
Africa
13
Myanmar / Burma
13
Lesotho
12
Congo, Democratic Republic of
12
Ukraine
10
Syria
10
Eastern Europe and Central Asia
9
Namibia
9
Zimbabwe
8
Indonesia
8
Eswatini/ Swaziland
7
Pakistan
7
Afghanistan
6
Cameroon
5
Guinea
5
Cambodia
5
West and Central Africa
5
Russia
5
South Sudan
5
Colombia
4
Turkey
3
USA
3
Venezuela
3
East and Southern Africa
3
Sri Lanka
3
Angola
3
Libya
3
North Macedonia
2
Tajikistan
2
Thailand
2
Kazakhstan
2
Iran
2
Albania
2
Laos
2
Kyrgyzstan
2
Burkina Faso
2
Mongolia
2
Mozambique
2
Italy
2
Middle East and North Africa
2
Western Pacific Region
2
North America
2
Jamaica
2
United Kingdom
2
Bosnia and Herzegovina
2
Argentina
2
Vietnam
2
Brazil
2
Egypt
2
Sudan
2
Yemen
2
Georgia
2
Bhutan
2
Botswana
2
Iraq
2
Somalia
2
North Korea
1
Timor Leste/ East Timor
1
Benin
1
Fiji
1
Senegal
1
Qatar
1
Armenia
1
Guinea-Bissau
1
Lithuania
1
Jordan
1
Saudi Arabia
1
Mauritius
1
Portugal
1
Spain
1
Israel
1
Côte d’Ivoire / Ivory Coast
1
Lebanon
1
Moldova
1
Djibouti
1
Palestine
1
Chad
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Countries
599
Clinical Guidelines
203
Public Health
125
Women & Child Health
124
Key Resources
90
Capacity Building
39
Pharmacy & Technologies
32
Toolboxes
Mental Health
121
HIV
116
TB
111
COVID-19
85
Caregiver
80
Disability
79
NTDs
63
Planetary Health
56
Refugee
48
AMR
46
Rapid Response
36
Global Health Education
35
Pharmacy
30
Conflict
28
Ebola & Marburg
27
NCDs
20
Malaria
20
2.0 Rapid Response
20
Specific Hazards
18
Natural Hazards
17
Health Financing Toolbox
14
Polio
13
Cholera
10
Zika
10
Social Ethics
4
Typhoon
1
ECDC Technical Report
In line with ECDC’s recommendations provided in the ’Risk Assessment of HTLV-1/2 transmission by tissue/cell transplantation’ dated 14 March 2012, this Directive replaces the term ‘incidence’ with ‘prevalence’ in the description of endemic areas of HTLV-1/2 i...
In line with ECDC’s recommendations provided in the ’Risk Assessment of HTLV-1/2 transmission by tissue/cell transplantation’ dated 14 March 2012, this Directive replaces the term ‘incidence’ with ‘prevalence’ in the description of endemic areas of HTLV-1/2 i...
Guideline ‒ Alternative mass drug administration regimens to eliminate lymphatic filariasis
recommended
Lymphatic filariasis is a vector-borne neglected tropical disease that causes damage of the lymphatic system and can lead to lymphoedema (elephantiasis) and hydrocele in infected individuals. The global baseline estimate of persons affected by lymphatic filariasis is 25 million men with hydrocele an...
Cognizant of the need for standardization of the response for COVID-19, the Federal Ministry of Health prepared this national guideline in an effort to contain the epidemic before it overwhelms the health care facilities. This national guideline is expected to guide policy makers and h...
беларускі - Belorussian
As part of the Mental Health Gap Action Programme, WHO has developed training manuals (Training of trainers and supervisors training manual and Training of health-care providers training manual) to support implementation of the mhGAP Intervention Guide for mental, neurological and substance use (MNS...
mhGAP is based on evidence-based technical guidelines (4) and provides a set of tools and
training packages to extend service provision. The mhGAP Intervention Guide (mhGAP-IG)
for MNS disorders in non-specialized health settings (8) is a clinical decision-making tool
for assessing and managing p...
Caring for the Sick Child age 2 months up to 5 years. Chart Booklet
2nd edition
For the first time WHO and UNICEF bring together the data on sanitation coverage and investment, and how it impacts health, economies, and the environment. Citing evidence on what works from successful countries and global guidelines, WHO and UNICEF call for strong government leadership and investme...
The purpose of this guidance is to assist WHO Member States, and other stakeholders, in the establishment and development of programmes of integrated surveillance of antimicrobial resistance in foodborne bacteria (i.e., bacteria commonly transmitted by food). In this guidance, “integrated surveill...
The global emergence of antimicrobial resistance (AMR) is posing a threat to human health. Putting resources into the containment of AMR – including surveillance – is one of the highest-yield investments a country can make to mitigate its impact. In 2015, WHO launched the Global Antimicrobial Re...
Atlas of African Health Statistics 2022: Health situation analysis of the WHO African Region
Since 2019, we have been implementing Phase 2 of the regional Transformation Agenda, which informs and aligns with the global WHO Transformation, to ensure WHO is accountable, driven by re- sults and provid...
Acta Trop. 2020 Mar:203:105289. doi: 10.1016/j.actatropica.2019.105289
The role of malacological surveys to identify potential transmission sites for schistosomiasis control in this era of
mass drug administration have received little attention. In that context, the present study was conducted to
...
The WHO Guidelines on physical activity and sedentary behaviour provide evidence-based public health recommendations for children, adolescents, adults and older adults on the amount of physical activity (frequency, intensity and duration) required to offer significant health benefits and mitigate he...
Inequality of access to palliative care and symptom relief is one of the greatest disparities in global health care (1). Currently, there is avoidable suffering on a massive scale due to lack of access to palliative care and symptom relief in low- and middle-income countries (LMICs) (1). Yet basic p...
In case of resistance to rifampicin, fluoroquinolones become the preferred category of second-line drugs. Unfortunately, quinolone-resistant strains of Mycobacterium leprae have also been reported in several countries, probably due to the extensive use of quinolones for treating several types of inf...
